Business Context and Reporting Period
SeaStar Medical Holding Corp (ICU) filed a Form 8-K on March 28, 2025, reporting the results of a special meeting of stockholders held virtually on that date. The meeting was convened to address proposals required for compliance with Nasdaq Listing Rule 5635(d).
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes
The primary material event reported is the successful approval of three proposals by the stockholders:
- Proposal 1: Approval of the issuance of Common Warrants and Common Warrant Shares upon exercise.
- Proposal 2: Approval of the extension of the term of the Company's Series B Warrants.
- Proposal 3: Approval of a proposal to adjourn or postpone the Special Meeting if necessary to solicit further votes.
Voting Results and Management Commentary
Management reported the following voting outcomes for the approved proposals:
| Proposal | Votes For | Votes Against | Abstentions |
|---|---|---|---|
| Issuance of Common Warrants | 2,116,949 | 293,443 | 9,916 |
| Extension of Series B Warrants | 2,117,817 | 292,249 | 10,242 |
| Adjournment/Postponement | 2,119,244 | 295,083 | 5,981 |
The filing does not provide specific forward-looking guidance, risk factors, or unusual items beyond the context of the warrant transactions.
Investor Verification Checklist
- Verify the specific terms of the newly issued Common Warrants and the extended Series B Warrants in subsequent filings or the definitive warrant agreements.
- Confirm the impact of the warrant issuance on the company's share count and potential dilution.
- Review the company's latest 10-K or 10-Q for financial health metrics, as this 8-K contains no financial data.